Clinical Trial

First-into-human Study of NS-136 in Healthy Subjects

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to exlplore the profile of NS-136 in health conditions. The main questions it aims to answer are: * Is NS-136 safe and tolerable in heathy subjects under tested dosing regimen? * What is the pharmacokinectic profile of NS-136 in healthy subjects under tested dosing regimen?
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-04-01; most recent amendment 2024-11-15.
Status change: Not Yet Recruiting → Recruiting 2024-05-13
Trial Details
NCT Number NCT06345703
Lead Sponsor NeuShen Therapeutics
Conditions Healthy Subjects
Enrollment 76 participants
Start Date 2024-04-30
Primary Completion 2024-11 (estimated)
Study Completion 2025-02 (estimated)
Updated on ClinicalTrials.gov 2024-11-19